Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8952974 | 1.00 | DNM1 (0.44) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| SCHEMBL17231131 | 1.00 | DNM1 (0.44) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| SCHEMBL5382087 | 1.00 | DNM1 (0.44) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| SCHEMBL7688203 | 1.00 | DNM1 (0.44) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| Ammonia Solution, Strong SCHEMBL28736955 | 0.98 | DNM1 (0.42) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| Hydrochloric Acid SCHEMBL28455833 | 0.98 | DNM1 (0.46) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| SCHEMBL3313941 | 0.95 | DNM1 (0.50) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| SCHEMBL18532757 | 0.92 | DNM1 (0.38) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| SCHEMBL29286456 | 0.91 | OPRM1 (0.42) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 | |
| SCHEMBL3307254 | 0.91 | DNM1 (0.44) | DNM1OPRM1PLA2G1BPLA2G2ASPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9428438-B2 | Process for preparing formic acid | BASF SE (DE) | 2016-08-30 | — | — | US | disclosed |
| EP-2925715-A1 | METHOD FOR PRODUCING FORMIC ACID | BASF SE (DE) | 2015-10-07 | — | — | EP | disclosed |
| EP-2794539-B1 | METHOD FOR PRODUCING FORMIC ACID | BASF SE (DE) | 2015-05-27 | — | — | EP | disclosed |
| US-8889905-B2 | Process for preparing formic acid | BASF SE (DE) | 2014-11-18 | — | — | US | disclosed |
| EP-2794540-A1 | PROCESS FOR PREPARING FORMIC ACID | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| EP-2794539-A1 | METHOD FOR PRODUCING FORMIC ACID | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-8835683-B2 | Process for preparing formic acid | BASF SE (DE) | 2014-09-16 | — | — | US | disclosed |
| WO-2014082845-A1 | METHOD FOR PRODUCING FORMIC ACID | BASF SE (DE) | 2014-06-05 | — | — | WO | disclosed |
| US-20140148617-A1 | PROCESS FOR PREPARING FORMIC ACID | BASF SE (DE) | 2014-05-29 | — | — | US | disclosed |
| US-20140018456-A1 | PROCESS FOR PREPARING FORMIC ACID | BASF SE (DE) | 2014-01-16 | — | — | US | disclosed |
| US-20130190532-A1 | PROCESS FOR PREPARING FORMIC ACID | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| WO-2013092403-A1 | METHOD FOR PRODUCING FORMIC ACID | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092157-A1 | PROCESS FOR PREPARING FORMIC ACID | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148617-A1 | PROCESS FOR PREPARING FORMIC ACID | MSMO1, FEN1, MED1 | DNM1 136/4885OPRM1 969/4885PLA2G1B 533/4885 |
| US-20140018456-A1 | PROCESS FOR PREPARING FORMIC ACID | F2, F5, FAH | DNM1 2185/4885OPRM1 3819/4885PLA2G1B 3150/4885 |
| US-20130190532-A1 | PROCESS FOR PREPARING FORMIC ACID | F5, F12, ADH1A | DNM1 1212/4885OPRM1 1219/4885PLA2G1B 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.